• Investing
  • Stock
Round Table Thoughts
  • Economy
  • Editor’s Pick
Home Investing Jefferies analyst reveals his top two biotech stocks for 2023
Investing

Jefferies analyst reveals his top two biotech stocks for 2023

by December 28, 2022
by December 28, 2022 0 comment
Share
0
FacebookTwitterPinterestWhatsapp

Moderna Inc (NASDAQ: MRNA) has tanked nearly 15% in recent days but a Jefferies analyst dubs it one of his best ideas for 2023.

Moderna stock could climb another 50%

Earlier in December, the biotech company said its candidate vaccine for skin cancer showed encouraging results in a Phase II study (read more). That’s what Michael Yee is most bullish about.  

I think that story will continue to unfold in 2023. Partner Merck is very bullish on this programme and opening up a lot of studies, including in lung cancer. So, it’s the first chapter and an important development.

The Nasdaq-listed firm will soon report Phase III data for its experimental RSV vaccine as well. Yee sees that as another reason to buy Moderna stock.  

He now sees upside in “MRNA” to $275 – up another 50% from here.

Yee is also bullish on the Amgen stock

A legacy name within “biotech” that pops out to Jefferies’ Michael Yee is Amgen Inc (NASDAQ: AMGN) that’s already up more than 15% for the year. Explaining why on CNBC’s “Closing Bell”, he said:

A more defensive large biotech company like Amgen is quite attractive in this difficult environment. [Also] in an offensive position where a renaissance of pipeline that has been going under appreciated.

The analyst is also constructive on its obesity drug currently named “AMG133” that was recently shown to have promising durability. Yee values the market for obesity drug at $20 billion to $50 billion.  

Earlier this month, Amgen Inc revealed plans of buying Horizon Therapeutics Plc for nearly $28 billion.

The post Jefferies analyst reveals his top two biotech stocks for 2023 appeared first on Invezz.

You Might Also Like
  • Decred launches new social media platform Bison Relay
  • Is it safe to buy the Carvana stock dip?
  • Top 4 US banks reporting quarterly earnings this week
  • MULN stock price forecast: Is it safe to buy Mullen Automotive?
Share
0
FacebookTwitterPinterestWhatsapp

previous post
This is what you should expect from U.S. stocks in Q1 of 2023
next post
Galaxy to acquire Helios Bitcoin mining facility from Argo Blockchain

You may also like

This is what you should expect from U.S. stocks in...

December 27, 2022

Core Scientific reveals $434 million loss in Q3

November 23, 2022

Is the cheap Kodal Minerals share price a buy now?

December 20, 2022

S&P 500 will keep within this range in 2023: David...

December 6, 2022

VIDEO: Forex markets – 2022 review and future predictions

December 9, 2022

Harnessing Monte Carlo Simulations for Options Trading: A Strategic Approach

October 22, 2024

Is it safe to buy the Carvana stock dip?

November 23, 2022

2023 is not the year to own Target stock: Wells...

January 4, 2023

Is the FTSE 100 a buy ahead of BoE and...

December 13, 2022

Options Trading Strategy: Bear Put Spread

May 12, 2023

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • From Oversold to Opportunity: Small Caps on the Move

      July 3, 2025
    • Money’s Not Leaving the Market — It’s Rotating!

      July 3, 2025
    • Tariffs and weaker beer demand are weighing on Modelo owner Constellation Brands

      July 3, 2025
    • Microsoft laying off about 9,000 employees in latest round of cuts

      July 3, 2025
    • Missed Disney’s Rally? Grab This Defined-Risk Put Spread for a Second Chance

      July 2, 2025

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese...

      June 25, 2024 3,628 views
    • 2

      Trump-era China sanctions ended by Biden may be...

      June 27, 2024 2,910 views
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as...

      August 9, 2024 2,601 views
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful...

      July 10, 2024 2,566 views
    • 5

      Harris VP pick spent years promoting research facility...

      August 29, 2024 2,442 views

    Categories

    • Economy (7,009)
    • Editor's Pick (2,162)
    • Investing (538)
    • Stock (2,652)

    Popular Posts

    • 1

      Biden appointee played key role in recruiting Chinese businesses to Delaware: ‘Longtime friends’

      June 25, 2024
    • 2

      Trump-era China sanctions ended by Biden may be revived under new House GOP bill

      June 27, 2024
    • 3

      Walz’s honeymoon with China gets fresh scrutiny as Harris camp blasts ‘lying’ critics

      August 9, 2024
    • 4

      Shein’s global ambitions leaves some cybersecurity experts fearful of Chinese spy threats

      July 10, 2024
    • 5

      Harris VP pick spent years promoting research facility that collaborated with ‘Chinese military company’

      August 29, 2024

    Latest News

    • From Oversold to Opportunity: Small Caps on the Move

      July 3, 2025
    • Money’s Not Leaving the Market — It’s Rotating!

      July 3, 2025
    • Tariffs and weaker beer demand are weighing on Modelo owner...

      July 3, 2025

    Categories

    • Economy (7,009)
    • Editor's Pick (2,162)
    • Investing (538)
    • Stock (2,652)

    Disclaimer: RoundTableThoughts.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2024 RoundTableThoughts.com. All Rights Reserved.

    Round Table Thoughts
    • Investing
    • Stock
    Round Table Thoughts
    • Economy
    • Editor’s Pick

    Read alsox

    Metacade token MCADE to list on...

    December 23, 2022

    Compass Inc will turn free cash...

    January 9, 2023

    Why You Should Never Use a...

    February 15, 2023
    Sign In

    Keep me signed in until I sign out

    Forgot your password?

    Password Recovery

    A new password will be emailed to you.

    Have received a new password? Login here